H. Moses Murdock

1.2k total citations · 1 hit paper
15 papers, 492 citations indexed

About

H. Moses Murdock is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, H. Moses Murdock has authored 15 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 4 papers in Public Health, Environmental and Occupational Health and 2 papers in Molecular Biology. Recurrent topics in H. Moses Murdock's work include Acute Myeloid Leukemia Research (7 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Innovations in Medical Education (2 papers). H. Moses Murdock is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Innovations in Medical Education (2 papers). H. Moses Murdock collaborates with scholars based in United States, Australia and Canada. H. Moses Murdock's co-authors include Jaya Aysola, Elle Lett, Whitney Orji, Ronnie Sebro, Saman Nematollahi, Helen C. Su, Alexandra F. Freeman, Huie Jing, Ronald N. Germain and Devon Chandler‐Brown and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Frontiers in Immunology.

In The Last Decade

H. Moses Murdock

14 papers receiving 489 citations

Hit Papers

Trends in Racial/Ethnic Representation Among US Medical S... 2019 2026 2021 2023 2019 50 100 150 200

Peers

H. Moses Murdock
Michelle Wise New Zealand
Leslie S. Jones United States
Matthew Mansh United States
Janis P. Tupesis United States
Valentin Barsan United States
Douglas V. Horbelt United States
Margaret E. Long United States
Michelle Wise New Zealand
H. Moses Murdock
Citations per year, relative to H. Moses Murdock H. Moses Murdock (= 1×) peers Michelle Wise

Countries citing papers authored by H. Moses Murdock

Since Specialization
Citations

This map shows the geographic impact of H. Moses Murdock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Moses Murdock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Moses Murdock more than expected).

Fields of papers citing papers by H. Moses Murdock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Moses Murdock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Moses Murdock. The network helps show where H. Moses Murdock may publish in the future.

Co-authorship network of co-authors of H. Moses Murdock

This figure shows the co-authorship network connecting the top 25 collaborators of H. Moses Murdock. A scholar is included among the top collaborators of H. Moses Murdock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Moses Murdock. H. Moses Murdock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Murdock, H. Moses, Kyle Hebert, Edoardo Auriemma, et al.. (2025). Ven+FluBu2 with ptcy/tac/MMF RIC transplant followed by venetoclax/azacitidine maintenance for high-risk MDS/AML. Blood. 146(Supplement 1). 4206–4206.
2.
Murdock, H. Moses, Vincent T. Ho, & Jacqueline S. Garcia. (2024). Innovations in conditioning and post-transplant maintenance in AML: genomically informed revelations on the graft-versus-leukemia effect. Frontiers in Immunology. 15. 1359113–1359113. 5 indexed citations
3.
Shimony, Shai, H. Moses Murdock, Christopher R. Reilly, et al.. (2024). AML-MR Mutations Drive the Benefit of CPX-351 over 7+3 in the Pivotal Phase 3 AML Trial. Blood. 144(Supplement 1). 60–60. 2 indexed citations
4.
Gooptu, Mahasweta, H. Moses Murdock, & Robert J. Soiffer. (2024). How I treat AML relapse after allogeneic HSCT. Blood. 145(19). 2128–2137. 1 indexed citations
5.
Aysola, Jaya, H. Moses Murdock, Elle Lett, et al.. (2023). Operationalizing inclusion: moving from an elusive goal to strategic action. Epidemiologic Reviews. 45(1). 140–145. 1 indexed citations
6.
Tsai, Harrison, Christopher J. Gibson, H. Moses Murdock, et al.. (2022). Allelic complexity of KMT2A partial tandem duplications in acute myeloid leukemia and myelodysplastic syndromes. Blood Advances. 6(14). 4236–4240. 7 indexed citations
7.
Murdock, H. Moses, et al.. (2021). Morning report goes virtual: learner experiences in a virtual, case-based diagnostic reasoning conference. Diagnosis. 9(1). 89–95. 2 indexed citations
8.
Murdock, H. Moses, Erika H. Dawson, Roy H. Hamilton, et al.. (2021). A New Way of Evaluating Effectiveness of URM Summer Pipeline Programs. Advances in Medical Education and Practice. Volume 12. 863–869. 5 indexed citations
9.
Murdock, H. Moses, et al.. (2020). Virtual Morning Report during COVID‐19: A novel model for case‐based teaching conferences. Medical Education. 54(9). 851–852. 45 indexed citations
10.
Gibson, Christopher J., Haesook T. Kim, H. Moses Murdock, et al.. (2020). DNMT3A clonal Hematopoiesis in Older Donors Is Associated with Improved Survival in Recipients after Allogeneic Hematopoietic Cell Transplant. Blood. 136(Supplement 1). 26–26. 6 indexed citations
11.
Lindsley, R. Coleman, Christopher J. Gibson, H. Moses Murdock, et al.. (2019). Genetic Characteristics and Outcomes By Mutation Status in a Phase 3 Study of CPX-351 Versus 7+3 in Older Adults with Newly Diagnosed, High-Risk/Secondary Acute Myeloid Leukemia (AML). Blood. 134(Supplement_1). 15–15. 27 indexed citations
12.
Lett, Elle, H. Moses Murdock, Whitney Orji, Jaya Aysola, & Ronnie Sebro. (2019). Trends in Racial/Ethnic Representation Among US Medical Students. JAMA Network Open. 2(9). e1910490–e1910490. 235 indexed citations breakdown →
13.
Murdock, H. Moses, Haesook T. Kim, Pankit Vachhani, et al.. (2019). Genetic Alterations at Diagnosis Predict Outcome of AML Patients Age 60 or Older Undergoing Allogeneic Transplantation in First Remission. Blood. 134(Supplement_1). 48–48. 3 indexed citations
14.
Cuellar‐Rodríguez, Jennifer, Alexandra F. Freeman, Jennifer Grossman, et al.. (2015). Matched Related and Unrelated Donor Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency. Biology of Blood and Marrow Transplantation. 21(6). 1037–1045. 31 indexed citations
15.
Zhang, Qian, Christopher G. Dove, Jyh Liang Hor, et al.. (2014). DOCK8 regulates lymphocyte shape integrity for skin antiviral immunity. The Journal of Experimental Medicine. 211(13). 2549–2566. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026